Skip to content
Preprint · CC-BY via OpenAlex

Resveratrol: Twenty Years of Growth, Development and Controversy

John Michael Pezzuto

Biomolecules & Therapeutics · 2018 · ▲ 175 citations

Abstract

. 5 to 5,000 mg/day) and variable experimental settings. Further, molecular targets are numerous and a dominant mechanism is elusive or nonexistent. In this context, the compound is overtly promiscuous. Nonetheless, since the safety profile is pristine, and use as a dietary supplement is prevalent, these features are not viewed as detrimental. Given the ongoing history of resveratrol, it is reasonable to advocate for additional development and further clinical investigation. Topical preparations seem especially promising, as do conditions that can respond to anti-inflammatory action and/or direct exposure, such as colon cancer prevention. Although the ultimate fate of resveratrol remains an open question, thus far, the compound has inspired innovative scientific concepts and enhanced public awareness of preventative health care.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4062/biomolther.2018.176
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Pezzuto, J.M. (2018). Resveratrol: Twenty Years of Growth, Development and Controversy. <em>Biomolecules & Therapeutics</em>. https://doi.org/10.4062/biomolther.2018.176
Vancouver
Pezzuto JM. Resveratrol: Twenty Years of Growth, Development and Controversy. Biomolecules & Therapeutics. 2018. doi:10.4062/biomolther.2018.176.
BibTeX
@unpublished{john2018Resver, title = {Resveratrol: Twenty Years of Growth, Development and Controversy}, author = {John Michael Pezzuto}, journal = {Biomolecules & Therapeutics}, year = {2018}, doi = {10.4062/biomolther.2018.176}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings